Activation-inhibitor

 
       
  • 活性抑制剂

Activation-inhibitor的用法和样例:

例句

  1. Highly active inhibitor of fibrinolysin and chymotrypsin.
    溶纤维蛋白酶和胰凝乳蛋白酶的高活性抑制剂。
  2. Objective:To examine whether VLDL or LDL can stimulate the secretion of plasminogen activator inhibitor type 1 (PAI-1) in hepatic cells.
    目的 :观察极低密度脂蛋白 (VL DL)与低密度脂蛋白 (L DL)是否能刺激肝细胞纤溶酶原激活物抑制物 - 1(PAI- 1)的分泌。
  3. Plasminogen activator(PA) and plasminogen activator inhibitor(PAI) are involved in many physiological or pathological events.
    纤溶酶原激活因子(PA)及其抑制因子(PAI)参与机体的多种生理、病理活动。
  4. ObjectiveTo investigate the activity of tissue plasminogen activator(t-PA) and plasminogen activator inhibitor(PAI) in patients with hypertensive disorder complicating pregnancy.
    目的探讨妊娠期高血压疾病患者血浆组织型纤溶酶原激活物(t-PA)及其抑制物(PAI)的活性变化。
  5. The COC1 expressed the mRNAs of matrix metalloproteinase 2 (MMP-2), tissue inhibitor of metalloproteinase-2 (TIMP-2) and plasminogen activator inhibitor type 1 (PAI-1), but not those of MMP-9, TIMP-1 or urokinase-type plasminogen activator (u-PA).
    卵巢癌细胞株COC1表达基质金属蛋白酶2(MMP-2)、基质金属蛋白酶抑制剂(TIMP-2)及纤溶酶原抑制剂(PAI-1),而不表达MMP-9、TIMP-1及尿激酶型纤溶酶原激活物(u-PA)。
  6. Methods Activities of tissue type plasminogen activator(t PA) and plasminogen activator inhibitor(PAI) and contents of D dimeter(D D) and fibrinogen(FbG) were determined in 22 patients with TIA and compared with 22 normal controls.
    方法 对 2 2例颈内动脉系统TIA患者血浆组织型纤溶酶原激活物 (t PA)及其快速抑制物 (PAI)的活性、D 二聚体 (D D)及纤维蛋白原 (FbG)含量进行检测 ,并与对照组进行比较。

Activation-inhibitor的海词问答与网友补充:

提问补充

Activation-inhibitor的相关资料:

临近单词

目录
应用 附录 查词历史
    更多>>今日热词